
IndraLab
Statements
reach
"In addition, the results from the present study demonstrate that RvD2 could promote the degradation of NLRP3 inflammasome and may induce the inhibition of NLRP3 inflammasome activation.LPS intraperitoneal injection was previously reported to stimulate inflammasome activation in peritoneal macrophages (1)."
reach
"In vivo, in a self resolving zymosan A induced peritonitis model, RvD2 blocked the NLRP3 inflammasome leading to reduced release of IL-1beta into the exudates, repression of osteopontin, and MCP-1 expression and induction of M2 markers of resolution (i.e., CD206 and arginase-1) in peritoneal macrophages."